Patents by Inventor Thomas Schreck

Thomas Schreck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10709881
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: May 8, 2017
    Date of Patent: July 14, 2020
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau
  • Publication number: 20200022918
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Application
    Filed: January 9, 2019
    Publication date: January 23, 2020
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Lawrence HAMEL, Andrew I. POUTIATINE
  • Patent number: 10507180
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: December 17, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Patent number: 10342762
    Abstract: Small-volume oral transmucosal dosage forms or NanoTabs® comprising a predetermined amount of a pharmaceutically active drug are provided. Exemplary applications include use of the NanoTabs® to administer a drug for the treatment of acute, post-operative or breakthrough pain.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: July 9, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, Andrew I. Poutiatine
  • Publication number: 20190125659
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: October 5, 2018
    Publication date: May 2, 2019
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Patent number: 10245228
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: April 2, 2019
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Publication number: 20180161270
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: July 20, 2017
    Publication date: June 14, 2018
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Publication number: 20170259051
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Application
    Filed: May 8, 2017
    Publication date: September 14, 2017
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Andrew POUTIATINE, Charles RAMPERSAUD, Bruce EDWARDS, Edmond CHIU, Thomas SCHRECK, Stelios TZANNIS, Lawrence HAMEL, William KOLOSI, Sascha RETAILLEAU
  • Patent number: 9744129
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: April 6, 2016
    Date of Patent: August 29, 2017
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Patent number: 9687263
    Abstract: Devices that are adapted to insert a sinus dilator into a stenotic opening of a paranasal sinus of a subject using minimally invasive dilator insertion procedures are provided. The devices and methods can be used to treat sinusitis and other nasal and/or sinus disorders.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: June 27, 2017
    Assignee: SinuSys Corporation
    Inventors: Thomas A. Schreck, Jerome E. Hester, David E. Edgren, William Jason Fox, Curtis Leslie Rieser
  • Patent number: 9642996
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: May 9, 2017
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Lawrence Hamel, William Kolosi, Sascha Retailleau
  • Patent number: 9629644
    Abstract: Medical devices which are adapted to be implanted into a patient for a limited period of time using minimally invasive insertion procedures for dilating a stenotic opening, such as a stenotic sinus opening, are provided. The devices and methods can be used for treating sinusitis and other nasal and/or sinus disorders.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: April 25, 2017
    Assignee: SinuSys Corporation
    Inventors: Thomas A. Schreck, Jerome E. Hester, David E. Edgren, Andrew I. Poutiatine, Curtis L. Rieser
  • Patent number: 9597485
    Abstract: Medical devices which are adapted to be inserted into a patient for a limited period of time using minimally invasive insertion procedures for dilating a stenotic opening, such as a stenotic sinus opening, are provided. The devices and methods can be used for treating sinusitis and other nasal and/or sinus disorders.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: March 21, 2017
    Assignee: SinuSys Corporation
    Inventors: David E. Edgren, William Jason Fox, William L. Gould, Jerome E. Hester, Bradley F. Marple, Curtis Leslie Rieser, Thomas A. Schreck
  • Patent number: 9504812
    Abstract: Medical devices which are adapted to be inserted into a patient for a limited period of time using minimally invasive insertion procedures for dilating a stenotic opening, such as a stenotic sinus opening, are provided. The devices and methods can be used for treating sinusitis and other nasal and/or sinus disorders.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: November 29, 2016
    Assignee: SinuSys Corporation
    Inventors: David E. Edgren, William Jason Fox, William L. Gould, Jerome E. Hester, Bradley F. Marple, Curtis Leslie Rieser, Thomas A. Schreck
  • Patent number: 9498239
    Abstract: Devices that are adapted to insert a sinus dilator into a stenotic opening of a paranasal sinus in a subject patient using minimally invasive insertion procedures are provided. The devices and methods can be used to treat sinusitis and other nasal and/or sinus disorders.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: November 22, 2016
    Assignee: SinuSys Corporation
    Inventors: Thomas A. Schreck, Jerome E. Hester, Andrew I. Poutiatine, Curtis L. Rieser
  • Publication number: 20160213606
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Application
    Filed: April 6, 2016
    Publication date: July 28, 2016
    Applicant: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela PALMER, Thomas SCHRECK, Stelios TZANNIS, Larry HAMEL, Andrew I. POUTIATINE
  • Patent number: 9320710
    Abstract: Compositions, systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject for treatment of pain using a device are disclosed.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: April 26, 2016
    Assignee: AcelRX Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Thomas Schreck, Stelios Tzannis, Larry Hamel, Andrew I. Poutiatine
  • Patent number: 9289583
    Abstract: Systems and methods for administration of small volume sufentanil drug dosage forms to the sublingual mucosa of a subject using a device are disclosed. The dispensing device includes a lock-out feature and a means to retard or prevent saliva and/or moisture ingress such that the drug dosage forms in the device remain dry prior to administration.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 22, 2016
    Assignee: AcelRx Pharmaceuticals, Inc.
    Inventors: Pamela Palmer, Andrew I Poutiatine, Charles Rampersaud, Bruce Edwards, Edmond Chiu, Thomas Schreck, Stelios Tzannis, Larry Hamel
  • Patent number: 9149616
    Abstract: Medical devices which are adapted to be inserted into a patient for a limited period of time using minimally invasive insertion procedures for dilating a stenotic opening, such as a stenotic sinus opening, are provided. The devices and methods can be used for treating sinusitis and other nasal and/or sinus disorders.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: October 6, 2015
    Assignee: SinuSys Corporation
    Inventors: David E. Edgren, William Jason Fox, William L. Gould, Jerome E. Hester, Bradley F. Marple, Curtis Leslie Rieser, Thomas A. Schreck
  • Patent number: 9138569
    Abstract: Medical devices which are adapted to be inserted into a patient for a limited period of time using minimally invasive insertion procedures for dilating a stenotic opening, such as a stenotic sinus opening, are provided. The devices and methods can be used for treating sinusitis and other nasal and/or sinus disorders.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: September 22, 2015
    Assignee: SinuSys Corporation
    Inventors: David E. Edgren, William Jason Fox, William L. Gould, Jerome E. Hester, Bradley F. Marple, Curtis Leslie Rieser, Thomas A. Schreck